BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31217963)

  • 1. A retrospective mixed-methods evaluation of a national ORS and zinc scale-up program in Uganda between 2011 and 2016.
    Lam F; Kirchhoffer D; Buluma DM; Kabunga L; Wamala-Mucheri PN; Schroder K; Battu A
    J Glob Health; 2019 Jun; 9(1):010504. PubMed ID: 31217963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing coverage of pediatric diarrhea treatment in high-burden countries.
    Schroder K; Battu A; Wentworth L; Houdek J; Fashanu C; Wiwa O; Kihoto R; Macharia G; Trikha N; Bahuguna P; Dabas H; Kirchoffer D; Muhirwe L; Mucheri P; Musoke A; Lam F
    J Glob Health; 2019 Jun; 9(1):0010503. PubMed ID: 31131105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of a national oral rehydration solution and zinc scale-up program in Kenya between 2011 and 2016.
    Lam F; Wentworth L; Cherutich P; Migiro S; Abdala K; Musyoka M; Ogolla S; Obudho M; Mwangi Z; Kihoto R; Cheruiyot C; Wariari B; Battu A; Schroder K
    J Glob Health; 2019 Jun; 9(1):010505. PubMed ID: 31293782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Program evaluation of an ORS and zinc scale-up program in 8 Nigerian states.
    Lam F; Abdulwahab A; Houdek J; Adekeye O; Abubakar M; Akinjeji A; Braimoh T; Ajeroh O; Stanley M; Goh N; Schroder K; Wiwa O; Ihebuzor N; Prescott MR
    J Glob Health; 2019 Jun; 9(1):010502. PubMed ID: 31073399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of enhanced detailing and mass media on community use of oral rehydration salts and zinc during a scale-up program in Gujarat and Uttar Pradesh.
    Lam F; Pro G; Agrawal S; Shastri VD; Wentworth L; Stanley M; Beri N; Tupe A; Mishra A; Subramaniam H; Schroder K; Prescott MR; Trikha N
    J Glob Health; 2019 Jun; 9(1):010501. PubMed ID: 30546870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with the co-utilization of oral rehydration solution and zinc for treating diarrhea among under-five children in 35 sub-saharan Africa countries: a generalized linear mixed effect modeling with robust error variance.
    Seifu BL; Legesse BT; Yehuala TZ; Kase BF; Asmare ZA; Mulaw GF; Tebeje TM; Mare KU
    BMC Public Health; 2024 May; 24(1):1329. PubMed ID: 38755544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theory-based formative research on oral rehydration salts and zinc use in Lusaka, Zambia.
    Greenland K; Chipungu J; Chilengi R; Curtis V
    BMC Public Health; 2016 Apr; 16():312. PubMed ID: 27067003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of price and convenience in use of oral rehydration salts to treat child diarrhea: A cluster randomized trial in Uganda.
    Wagner Z; Asiimwe JB; Dow WH; Levine DI
    PLoS Med; 2019 Jan; 16(1):e1002734. PubMed ID: 30677019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Private health care market shaping and changes in inequities in childhood diarrhoea treatment coverage: evidence from the analysis of baseline and endline surveys of an ORS and zinc scale-up program in Nigeria.
    Braimoh T; Danat I; Abubakar M; Ajeroh O; Stanley M; Wiwa O; Prescott MR; Lam F
    Int J Equity Health; 2021 Mar; 20(1):88. PubMed ID: 33789694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral rehydration solution coverage in under 5 children with diarrhea: a tri-country, subnational, cross-sectional comparative analysis of two demographic health surveys cycles.
    Gona PN; Gona CM; Chikwasha V; Haruzivishe C; Rao SR; Mapoma CC
    BMC Public Health; 2020 Nov; 20(1):1716. PubMed ID: 33198701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An external evaluation of the Diarrhea Alleviation through Zinc and ORS Treatment (DAZT) program in Gujarat and Uttar Pradesh, India.
    Lamberti LM; Taneja S; Mazumder S; LeFevre A; Black RE; Walker CL
    J Glob Health; 2015 Dec; 5(2):020409. PubMed ID: 26682045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic costs to caregivers of diarrhoea treatment among children below 5 in rural Gujarat India: findings from an external evaluation of the DAZT programme.
    Shillcutt SD; LeFevre AE; Fischer Walker CL; Taneja S; Black RE; Mazumder S
    Health Policy Plan; 2016 Dec; 31(10):1411-1422. PubMed ID: 27476499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LiST modelling with monitoring data to estimate impact on child mortality of an ORS and zinc programme with public sector providers in Bihar, India.
    Ayyanat JA; Harbour C; Kumar S; Singh M
    BMC Public Health; 2018 Jan; 18(1):103. PubMed ID: 29304779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diarrhea no more: does zinc help the poor? Evidence on the effectiveness of programmatic efforts to reach poorest in delivering zinc and ORS at scale in UP and Gujarat, India.
    LeFevre AE; Mohan D; Mazumder S; Lamberti LL; Taneja S; Black RE; Fischer-Walker CL
    J Glob Health; 2016 Dec; 6(2):021001. PubMed ID: 28154759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association between Provider Practice and Knowledge of ORS and Zinc Supplementation for the Treatment of Childhood Diarrhea in Bihar, Gujarat and Uttar Pradesh, India: A Multi-Site Cross-Sectional Study.
    Lamberti LM; Fischer Walker CL; Taneja S; Mazumder S; Black RE
    PLoS One; 2015; 10(6):e0130845. PubMed ID: 26098305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Childhood Diarrhea Treatment Practices in Ghana: A Pre-Post Evaluation of a Comprehensive Private-Sector Program.
    El-Khoury M; Banke K; Sloane P
    Glob Health Sci Pract; 2016 Jun; 4(2):264-75. PubMed ID: 27353619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate Management of Acute Diarrhea in Children Among Public and Private Providers in Gujarat, India: A Cross-Sectional Survey.
    Walker CL; Taneja S; LeFevre A; Black RE; Mazumder S
    Glob Health Sci Pract; 2015 May; 3(2):230-41. PubMed ID: 26085020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of oral rehydration therapy, zinc, and other treatments for diarrhoea among children under-five in sub-Saharan Africa.
    Ahinkorah BO; Aboagye RG; Seidu AA; Frimpong JB; Cadri A; Afaya A; Hagan JE; Yaya S
    PLoS One; 2022; 17(10):e0275495. PubMed ID: 36227873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring coverage in MNCH: current indicators for measuring coverage of diarrhea treatment interventions and opportunities for improvement.
    Fischer Walker CL; Fontaine O; Black RE
    PLoS Med; 2013; 10(5):e1001385. PubMed ID: 23667330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diarrhoeal disease morbidity and home treatment practices in Egypt.
    Jousilahti P; Madkour SM; Lambrechts T; Sherwin E
    Public Health; 1997 Jan; 111(1):5-10. PubMed ID: 9033217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.